Lyell Immunopharma
Developing next-generation T-cell therapies for patients with solid tumors.
biotech
Company facts
- Founded
- 2018
- Employees
- 300
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: LYEL
6 jobs
Point your AI agent at freehire and let it find you a job. A CLI and an MCP server over the whole job API — no browser.
Get the CLI →Developing next-generation T-cell therapies for patients with solid tumors.
Company facts